Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-02-037231
Filing Date
2002-09-30
Accepted
2002-09-30 16:27:51
Documents
13
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 10-K a2090192z10-k.htm 10-K 421743
3 EX 10(VVV) a2090192zex-10_vvv.htm EX-10.(VVV) 55310
4 EX 10(WWW) a2090192zex-10_www.htm EX-10.(WWW) 100159
5 EX 10(XXX) a2090192zex-10_xxx.htm EX-10.(XXX) 16923
6 EX 10(YYY) a2090192zex-10_yyy.htm EX-10.(YYY) 15977
7 EX 10(ZZZ) a2090192zex-10_zzz.htm EX-10.(ZZZ) 107609
8 EX 10(AAAA) a2090192zex-10_aaaa.htm EX-10.(AAAA) 99870
9 EXHIBIT 10(BBBB) a2090192zex-10_bbbb.htm EX-10.(BBBB) 27419
10 EX 21 a2090192zex-21.htm EX-21 1626
11 EX 23.1 a2090192zex-23_1.htm EX-23.1 2128
12 EX 99.1 a2090192zex-99_1.htm EX-99.1 2766
13 EX 99.2 a2090192zex-99_2.htm EX-99.2 2761
14 G567179.JPG g567179.jpg GRAPHIC 11127
  Complete submission text file 0000912057-02-037231.txt   868545
Mailing Address 617 LUSK BLVD SAN DIEGO CA 92121
Business Address 6175 LUSK BLVD SAN DIEGO CA 92121 8584105200
ALLIANCE PHARMACEUTICAL CORP (Filer) CIK: 0000736994 (see all company filings)

EIN.: 141644018 | State of Incorp.: NY | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-12950 | Film No.: 02776703
SIC: 2835 In Vitro & In Vivo Diagnostic Substances